Aspirin is associated with improved 30-day mortality in patients with sepsis-associated liver injury: a retrospective cohort study based on MIMIC IV database
Aspirin can reduce 30-day mortality in SALI patients, regardless of the dose or timing of administration. However, careful assessment based on individual differences is essential to ensure the safety and effectiveness of aspirin use.
Authors
- Mengting Chen (ORCID: https://orcid.org/0000-0001-6001-9270)
- Susu Cao (ORCID: https://orcid.org/0000-0002-5547-1948)
- Xuemei Hu (ORCID: https://orcid.org/0000-0001-9009-0983)
- Min Yang (ORCID: https://orcid.org/0000-0002-1957-0885)
- Jianbao Wang (ORCID: https://orcid.org/0000-0002-1774-5979)
- Yiwen Zhao (ORCID: https://orcid.org/0000-0002-7228-6859)
- Tianfeng Hua
Institutions
- Anhui Medical University (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-03-04
- DOI
- https://doi.org/10.3389/fphar.2025.1514392
- Citations
- 3
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.06